Concepedia

Hypocalcemia Following Pamidronate Administration for Bone Metastases of Solid Tumor

Christophe Champallou, Jean-Pierre Basuyau, Corine Veyret, P. Chinet, Marc Debled, Annie Chevrier, Marie-Hélène Grongnet, P Brunelle

Journal of Pain and Symptom Management · 2003 · 18 citations · 9 references

DOIFull text

Open access

Concepts

References

9

American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer

Bruce E. Hillner, James N. Ingle, James R. Berenson et al. · Journal of Clinical Oncology · 2000 · 383 citations

, , +17

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

PierFranco Conte, Jean Latreille, L. Mauriac et al. · Journal of Clinical Oncology · 1996 · 268 citations

, , +17

Prolonged, Symptomatic Hypocalcemia with Pamidronate Administration and Subclinical Hypoparathyroidism

Alita Mishra, Lisa L. Wong, Jacqueline Jonklaas · Endocrine · 2001 · 30 citations

, , +15

Hypoparathyroidism unmasked by alendronate

A S Kashyap, Surekha Kashyap · Postgraduate Medical Journal · 2000 · 27 citations · Full text

, , +12

Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia

E.C. Sims, P. Rogers, G. M. Besser et al. · Clinical Oncology · 1998 · 23 citations

, , +11